JOHNSON & JOHNSON is 356.4x more valuable than Nuvation Bio Inc. by market capitalization ($573.98 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVB | JNJ |
|---|---|---|
| Market cap | $1.61 B | $573.98 B |
| US-listed rank | #2262 | #20 |
| Revenue (latest FY) | $62.90M | $94.19B |
| Net income (latest FY) | -$204.63M | $26.80B |
| Net margin | -325.3% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 379 | 984 |
JOHNSON & JOHNSON is 356.4x more valuable than Nuvation Bio Inc. by market capitalization ($573.98 B vs $1.61 B).
In their latest fiscal years, Nuvation Bio Inc. reported $62.90M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Nuvation Bio Inc. and JOHNSON & JOHNSON, or browse the full rankings.